knowledge -WSS

knowledge

author：explore 2025-10-02 17:22:22 - browse：58

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.

Good morning. Today we have Andrew Joseph’s dispatch from a Barcelona hospital that developed its own CAR-T, an intriguing clue to how obesity drugs work in the (mouse) brain, and a win for toothbrushing vs. pneumonia.

Apple pauses sales of latest watches in patent battle

If you had an Apple Watch on your wish list for the holidays this year, you may need to reconsider. To comply with an import ban from the International Trade Commission imposed in October, Apple is pulling Apple Watches with blood oxygen-measuring capabilities — that is, Apple Watch Series 9 and Apple Watch Ultra 2 — from its website Thursday and from its stores Sunday. The ITC has ruled that Apple infringed on the patents of pulse oximeter company Masimo. President Biden has until Dec. 25 to approve or veto the import ban, but Apple decided to pause sales first. Older versions of the Apple Watch that track heart rate and physical activity will still be available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Inequities make cancer less preventable for women: report

leisure time

WSS

BioAge raises $170M for combination therapy with Zepbound

Intercept Pharmaceuticals sells itself for less than $1 billion

Covid vaccines: Private market messier than government rollout

'Revelatory' study finds a smoking impact that remains after quitting

Listen: Who gets the credit for GLP

Address the ethical violations that led to 'Three Identical Strangers'

leisure time

knowledge

Apple pauses sales of latest watches in patent battle

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Medicare details structure of new drug price negotiation program

Robert F. Kennedy is pitching centrism on health, even on abortion

Duchenne breakthrough therapy leaves behind pioneering families

Inequities make cancer less preventable for women: report

Novavax promises a turnaround & Lilly roils the obesity market

How digital tools helped lower hypertension in marginalized patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Intercept Pharmaceuticals sells itself for less than $1 billion

entertainment

Industry veterans launch new biotech VC with $310M

Medicare Advantage proposed rates disappoint insurers

Intercept Pharmaceuticals sells itself for less than $1 billion

Robert F. Kennedy is pitching centrism on health, even on abortion

PhRMA lawsuit over Medicare drug price negotiation tossed

FDA advisers vote against ALS treatment from BrainStorm

explore

leisure time

leisure time

knowledge